- Home
- FICO vs IQV Comparison
FICO vs IQV Comparison
Compare FICO & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FICO
- IQV
- Stock Information
- Founded
- FICO 1956
- IQV 1982
- Country
- FICO United States
- IQV United States
- Employees
- FICO N/A
- IQV N/A
- Industry
- FICO Business Services
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- FICO Consumer Discretionary
- IQV Health Care
- Exchange
- FICO Nasdaq
- IQV Nasdaq
- Market Cap
- FICO 46.5B
- IQV 38.1B
- IPO Year
- FICO 1987
- IQV 2013
- Fundamental
- Price
- FICO $2,339.91
- IQV $194.86
- Analyst Decision
- FICO Buy
- IQV Buy
- Analyst Count
- FICO 12
- IQV 16
- Target Price
- FICO $1,964.92
- IQV $256.60
- AVG Volume (30 Days)
- FICO 151.3K
- IQV 2.2M
- Earning Date
- FICO 11-06-2024
- IQV 10-31-2024
- Dividend Yield
- FICO N/A
- IQV N/A
- EPS Growth
- FICO 20.79
- IQV 27.98
- EPS
- FICO 20.45
- IQV 7.62
- Revenue
- FICO $1,717,526,000.00
- IQV $15,315,000,000.00
- Revenue This Year
- FICO $18.83
- IQV $3.68
- Revenue Next Year
- FICO $12.35
- IQV $4.89
- P/E Ratio
- FICO $112.93
- IQV $25.35
- Revenue Growth
- FICO 13.48
- IQV 3.10
- 52 Week Low
- FICO $1,057.70
- IQV $187.62
- 52 Week High
- FICO $2,402.52
- IQV $261.73
- Technical
- Relative Strength Index (RSI)
- FICO 70.76
- IQV 30.04
- Support Level
- FICO $2,232.38
- IQV $187.62
- Resistance Level
- FICO $2,305.30
- IQV $194.48
- Average True Range (ATR)
- FICO 62.73
- IQV 7.50
- MACD
- FICO 4.99
- IQV -1.67
- Stochastic Oscillator
- FICO 78.20
- IQV 14.34
About FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.